Literature DB >> 25520158

Multidisciplinary cancer care may impact on the postoperative mortality and survival of patients with oesophageal and oesophagogastric junction cancer: a retrospective cohort study.

M Galán1, L Farran, L Aliste, G Hormigo, H Aranda, C Bettonica, A M Boladeras, J M Botargues, M Calvo, G Creus, M E De Lama, J B Gornals, R Mast, M Miró, M J Paúles, J Robles, N Virgili, J M Borràs.   

Abstract

BACKGROUND: Modern management of Oesophageal and oesophagogastric junction (OGJ) cancers requires a multidisciplinary approach, which was implemented at our health centre in 2005. This study aimed to assess the impact of this change on clinical outcomes.
METHODS: A retrospective cohort study was conducted, covering all patients treated for oesophageal and OGJ cancer at the cancer centre established by the Bellvitge University Hospital and Catalonian Institute of Oncology, over two time periods, i.e. 2000-2004 and 2005-2008. Descriptive and multivariate analyses were performed using survival at 1 and 3 years as dependent variables.
RESULTS: Between 1 January 2000 and 31 December 2008, 586 patients were included. Number of patients with unknown stage at diagnosis was significantly reduced. Preoperative strategies at the oesophageal location clearly increased in the recent period. A multidisciplinary approach resulted in a significant reduction in surgical mortality (11.8 vs. 2 %) in the period 2005-2008. Analysis restricted to patients undergoing surgery with curative intent indicated a significant increase in 1- and 3-year survival in the latter period (68.4 vs. 89.8 and 38.2 vs. 57.1 %, respectively). Multivariate analysis showed that variables associated with improved survival were: age; tumour stage; radical intent of treatment (surgery and radical combined chemoradiotherapy); and therapeutic strategy.
CONCLUSION: Better selection of patients for therapy together with improved staging resulted in a significant improvement in 1- and 3-year survival in cases undergoing surgery with curative intent. These changes would support the adoption of a multidisciplinary approach to clinical decision-making in cases of oesophageal and OGJ cancer.

Entities:  

Mesh:

Year:  2014        PMID: 25520158     DOI: 10.1007/s12094-014-1221-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  28 in total

1.  Hospital volume and hospital mortality for esophagectomy.

Authors:  J J van Lanschot; J B Hulscher; C J Buskens; H W Tilanus; F J ten Kate; H Obertop
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

Review 2.  Epidemiologic trends in esophageal and gastric cancer in the United States.

Authors:  Linda Morris Brown; Susan S Devesa
Journal:  Surg Oncol Clin N Am       Date:  2002-04       Impact factor: 3.495

3.  Volume and process of care in high-risk cancer surgery.

Authors:  John D Birkmeyer; Yating Sun; Aaron Goldfaden; Nancy J O Birkmeyer; Therese A Stukel
Journal:  Cancer       Date:  2006-06-01       Impact factor: 6.860

Review 4.  A systematic review of the impact of volume of surgery and specialization on patient outcome.

Authors:  M M Chowdhury; H Dagash; A Pierro
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

5.  Oesophageal cancer treatment in a tertiary referral hospital evaluated by indicators for quality of care.

Authors:  E F W Courrech Staal; K M Bloemendal; M C Bloemer; B M P Aleman; A Cats; J W van Sandick
Journal:  Eur J Surg Oncol       Date:  2011-12-03       Impact factor: 4.424

6.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

7.  Impact of concentration of oesophageal and gastric cardia cancer surgery on long-term population-based survival.

Authors:  L V van de Poll-Franse; V E P P Lemmens; J A Roukema; J W W Coebergh; G A P Nieuwenhuijzen
Journal:  Br J Surg       Date:  2011-04-20       Impact factor: 6.939

8.  Case volume as a predictor of inpatient mortality after esophagectomy.

Authors:  Michael Rodgers; Blair A Jobe; Robert W O'Rourke; Brett Sheppard; Brian Diggs; John G Hunter
Journal:  Arch Surg       Date:  2007-09

Review 9.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Centralization of esophageal cancer surgery: does it improve clinical outcome?

Authors:  M W J M Wouters; H E Karim-Kos; S le Cessie; B P L Wijnhoven; L P S Stassen; W H Steup; H W Tilanus; R A E M Tollenaar
Journal:  Ann Surg Oncol       Date:  2009-04-16       Impact factor: 5.344

View more
  4 in total

1.  The Multidisciplinary Management of Cancer in Daily Clinical Practice: Towards a Community Hospital Comprehensive Cancer Center.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  J Gastrointest Cancer       Date:  2016-03

Review 2.  Multidisciplinary Approach to the Management of Esophageal Malignancies.

Authors:  Ranjit Joseph; Shachar Laks; Michael Meyers; Autumn J McRee
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

3.  Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre.

Authors:  Maria Saigí; Marc Oliva; Luisa Aliste; Mariona Calvo; Gloria Hormigo; Òlbia Serra; Anna Boladeras; Leandre Farran; Javier Robles; Gloria Creus; Ma José Paúles; Joan B Gornals; Eugenia de Lama; Josep Ma Borràs; Núria Sala; Maica Galán
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

4.  The Prognostic Effect of Multidisciplinary Team Intervention in Patients with Advanced Gastric Cancer.

Authors:  Yuan-Yuan Xiang; Cun-Can Deng; Han-Yuan Liu; Zi-Chong Kuo; Chang-Hua Zhang; Yu-Long He
Journal:  Curr Oncol       Date:  2022-02-17       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.